Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Fellow

Biomedical Sciences · Mexico · 2022-08-22

Processing Time
489 days
Decision Date
2022-08-22
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop a highly quantitative understanding of the interactions between cancer cells and the immune system. He utilizes high-resolution microscopy, high-throughput flow cytometry, and mathematical modeling to design personalized cancer immunotherapies that are more effective than current treatments.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on cancer immunotherapies was determined to have clear relevance and national worth to the United States healthcare sector.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, 156 citations, and history of federal funding demonstrate he is well-positioned to succeed.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner’s specialized expertise in high-resolution microscopy and mathematical modeling justifies a waiver of the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in biomedical sciences, 3 peer-reviewed journal articles, and 1 book chapter. The work earned 156 citations and received funding from the National Institutes of Health (NIH) and the National Science Foundation (NSF), satisfying the Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 467 days 2025-02-25
The petitioner proposes to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior. Her work focuses on improving the understanding of cancer pathogenesis and immunotherapy to accelerate the development of new therapeutic strategies.
View Case

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
New Jersey 180 days 2025-09-03
The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.
View Case

Scientist

Biotechnology · Australia

WeGreened EB-2 (NIW) approved
Texas 55 days 2022-03-25
The petitioner proposes to enhance cell-based therapies in preclinical and clinical stages by developing high-throughput technologies to assess and identify immune cells with a high degree of accuracy. This work focuses on advancing cancer therapeutics by elucidating the role of extracellular vesicles (EVs) in cancer metastasis.
View Case

Research Scientist

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Oklahoma 33 days 2025-09-10
The petitioner proposes to develop advanced preclinical cancer models to evaluate the efficacy and immune responses of novel immunotherapies, including cancer vaccines and antibody-drug conjugates. This work focuses on optimizing rational combination strategies to improve clinical outcomes for patients with treatment-resistant and aggressive cancers. The endeavor aims to bridge the gap between laboratory discovery and clinical application to make therapies safer and more accessible.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Mexico

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-08-22.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 489 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Mexico All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist